Роль эпидермального барьера в формировании пищевой аллергии у детей с генодерматозами
https://doi.org/10.15690/pf.v16i4.2053
Аннотация
В статье представлены наиболее распространенные в практике врачей дерматологов и педиатров генодерматозы, ассоциированные с высоким риском развития аллергических реакций, — ихтиоз и ихтиозиформные дерматозы, синдром Нетертона и другие ихтиозиформные эритродермии, синдромы пилинг-скин и SAM, а также врожденный буллезный эпидермолиз. Описаны патогенетические аспекты транскутанной сенсибилизации, развития пищевой аллергии и вышеперечисленных генодерматозов, приведены клинические случаи из собственной практики.
Об авторах
Н. Н. МурашкинРоссия
Контактная информация: Мурашкин Николай Николаевич, доктор медицинских наук, профессор, заведующий отделением дерматологии с группой лазерной хирургии ФГАУ «Национальный медицинский исследовательский центр здоровья детей» Минздрава России
Адрес: 119991, Москва, Ломоносовский пр-т, д. 2Р. А. Иванов
Россия
Москва
А. А. Савелова
Россия
Москва
Д. В. Федоров
Россия
Москва
Л. А. Опрятин
Россия
Москва
В. Ахмад
Россия
Кабардино-Балкарская Республика
Список литературы
1. Sicherer SH, Allen K, Lack G, et al. Critical issues in food allergy: A National Academies Consensus Report. Pediatrics. 2017;140(2). pii: e20170194. doi: 10.1542/peds.2017-0194.
2. Lodge CJ, Allen KJ, Lowe AJ, et al. Overview of evidence in prevention and aetiology of food allergy: a review of systematic reviews. Int J Environ Res Public Health. 2013;10(11):5781–5806. doi: 10.3390/ijerph10115781.
3. Sicherer SH, Sampson HA. Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol. 2014;133(2):291–307; quiz 308. doi: 10.1016/j.jaci.2013.11.020.
4. Jones SM, Burks AW. Food Allergy. N Engl J Med. 2017;377(12):1168–1176. doi: 10.1056/NEJMcp1611971.
5. Sicherer SH. Epidemiology of food allergy. J Allergy Clin Immunol. 2011;127(3):594–602. doi: 10.1016/j.jaci.2010.11.044.
6. Soller L, Ben-Shoshan M, Harrington DW, et al. Overall prevalence of self-reported food allergy in Canada. J Allergy Clin Immunol. 2012;130(4):986–988. doi: 10.1016/j.jaci.2012.06.029.
7. Nwaru BI, Hickstein L, Panesar SS, et al. The epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy. 2014;69(1):62–75. doi: 10.1111/all.12305.
8. Loh W, Tang ML. The epidemiology of food allergy in the global context. Int J Environ Res Public Health. 2018;15(9). pii: E2043. doi: 10.3390/ijerph15092043.
9. McGowan EC, Keet CA. Prevalence of self-reported food allergy in the National Health and Nutrition Examination Survey (NHANES) 2007–2010. J Allergy Clin Immunol. 2013;132(5):1216–1219.e5. doi: 10.1016/j.jaci.2013.07.018.
10. Gupta RS, Warren CM, Smith BM, et al. The public health impact of parent-reported childhood food allergies in the United States. Pediatrics. 2018;142(6). pii: e20181235. doi: 10.1542/peds.2018–1235.
11. Loke P, Koplin J, Beck C, et al. Statewide prevalence of school children at risk of anaphylaxis and rate of adrenaline autoinjector activation in Victorian government schools, Australia. J Allergy Clin Immunol. 2016;138(2):529–535. doi: 10.1016/j.jaci.2016.02.014.
12. Hu Y, Chen J, Li H. Comparison of food allergy prevalence among Chinese infants in Chongqing, 2009 versus 1999. Pediatr Int. 2010;52(5):820–824. doi: 10.1111/j.1442-200X.2010.03166.x.
13. Yu W, Freeland DM, Nadeau KC. Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat Rev Immunol. 2016;16(12):751–765. doi: 10.1038/nri.2016.111.
14. Mansoor DK, Sharma HP. Clinical presentations of food allergy. Pediatr Clin North Am. 2011;58(2):315–326, ix. doi: 10.1016/j.pcl.2011.02.008.
15. Bock SA, Muñoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001–2006. J Allergy Clin Immunol. 2007;119(4):1016–1018. doi: 10.1016/j.jaci.2006.12.622.
16. Colver AF, Nevantaus H, Macdougall CF, Cant AJ. Severe foodallergic reactions in children across the UK and Ireland, 1998– 2000. Acta Paediatr. 2007;94(6):689–695. doi: 10.1111/j.16512227.2005.tb01966.x.
17. Berin MC, Shreffler WG. Mechanisms underlying induction of tolerance to foods. Immunol Allergy Clin North Am. 2016;36(1):87– 102. doi: 10.1016/j.iac.2015.08.002.
18. Worbs T, Bode U, Yan S, et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med. 2006;203(3):519–527. doi: 10.1084/jem.20052016.
19. Sampson HA, O’Mahony L, Burks AW, et al. Mechanisms of food allergy. J Allergy Clin Immunol. 2018;141(1):11–19. doi: 10.1016/j. jaci.2017.11.005.
20. Brown SJ, Asai Y, Cordell HJ, et al. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol. 2011;127(3):661–667. doi: 10.1016/j.jaci.2011.01.031.
21. Пищевая аллергия. Клинические рекомендации [интернет]. — М.: Союз педиатров России, 2018. Доступно по: http://www.pediatr-russia.ru/sites/default/files/file/kr_pa2018.pdf. Ссылка активна на: 12.04.2019.
22. Posthumus J, James HR, Lane CJ, et al. Initial description of pork-cat syndrome in the United States. J Allergy Clin Immunol. 2013;131(3):923–925. doi: 10.1016/j.jaci.2012.12.665.
23. Brough HA, Liu AH, Sicherer S, et al. Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J Allergy Clin Immunol. 2015;135(1):164–170. doi: 10.1016/j.jaci.2014.10.007.
24. Amagai, Masayuki. The three musketeers of the epidermal barrier and atopic diseases. Cornea, 2014, November. 2014;33:S9. doi: 10.1097/ICO.0000000000000231.
25. Beck LA, Leung DY. Allergen sensitization through the skin induces systemic allergic responses. J Allergy Clin Immunol. 2000;106(5 Suppl):S258–263.
26. Bertelsen RJ, Faeste CK, Granum B, et al. Food allergens in mattress dust in Norwegian homes — a potentially important source of allergen exposure. Clin Exp Allergy. 2014;44(1):142–149. doi: 10.1111/cea.12231.
27. Izadi N, Luu M, Ong PY, Tam JS. The role of skin barrier in the pathogenesis of food allergy. Children (Basel). 2015;2(3):382–402. doi: 10.3390/children2030382.
28. Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest. 2012;122(2):440–447. doi: 10.1172/JCI57416.
29. Berin MC, Shreffler WG. T(h)2 adjuvants: implications for food allergy. J Allergy Clin Immunol. 2008;121(6):1311–1320; quiz 1321–1322. doi: 10.1016/j.jaci.2008.04.023.
30. Valenta R, Hochwallner H, Linhart B, Pahr S. Food allergies: the basics. Gastroenterology. 2015;148(6):1120–1131.e4. doi: 10.1053/j.gastro.2015.02.006.
31. Lexmond WS, Goettel JA, Sallis BF, et al. Spontaneous food allergy in Was-/mice occurs independent of FcεRI-mediated mast cell activation. Allergy. 2017;72(12):1916–1924. doi: 10.1111/all.13219.
32. Clark RA, Chong B, Mirchandani N, Mirchandani N. The vast majority of CLA+ T cells are resident in normal skin. J Immunol. 2006;176(7):4431–4439. doi: 10.4049/jimmunol.176.7.4431.
33. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev. 2002;82(1):97–130. doi: 10.1152/physrev.00023.2001.
34. Craiglow BG. Ichthyosis in the newborn. Semin Perinatol. 2013;37(1):26–31. doi: 10.1053/j.semperi.2012.11.001.
35. Oji V, Tadini G, Akiyama M, et al. Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol. 2010;63(4):607–641. doi: 10.1016/j.jaad.2009.11.020.
36. Wickett RR, Visscher MO. Structure and function of the epidermal barrier. Am J Infect Control. 2006;34(10, Suppl):S98–S110. doi: 10.1016/j.ajic.2006.05.295.
37. Egawa G, Kabashima K. Barrier dysfunction in the skin allergy. Allergol Int. 2018;67(1):3–11. doi: 10.1016/j.alit.2017.10.002.
38. Akiyama M. FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics. Br J Dermatol. 2010;162(3):472–477. doi: 10.1111/j.13652133.2009.09582.x.
39. Takeichi T, Okuno Y, Saito C, et al. Congenital ichthyosis and recurrent eczema associated with a novel ALOXE3 mutation. Acta Derm Venereol. 2017;97(4):532–533. doi: 10.2340/00015555-2549.
40. Bitoun E, Chavanas S, Irvine AD, et al. Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol. 2002;118(2):352–361. doi: 10.1046/j.15231747.2002.01603.x.
41. Deraison C, Bonnart C, Lopez F, et al. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol Cell. 2007;18(9):3607–3619. doi: 10.1091/mbc.e07-02-0124.
42. Briot A, Deraison C, Lacroix M, et al. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med. 2009;206(5):1135–1147. doi: 10.1084/jem.20082242.
43. Oji V, Eckl KM, Aufenvenne K, et al. Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease. Am J Hum Genet. 2010;87(2):274–281. doi: 10.1016/j.ajhg.2010.07.005.
44. Israeli S, Zamir H, Sarig O, et al. Inflammatory peeling skin syndrome caused by a mutation in CDSN encoding corneodesmosin. J Invest Dermatol. 2011;131(3):779–781. doi: 10.1038/jid.2010.363.
45. Samuelov L, Sarig O, Harmon RM, et al. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet. 2013;45(10):1244–1248. doi: 10.1038/ng.2739.
46. McAleer MA, Pohler E, Smith FJ, et al. Severe dermatitis, multiple allergies, and metabolic wasting syndrome caused by a novel mutation in the N-terminal plakin domain of desmoplakin. J Allergy Clin Immunol. 2015;136(5):1268–1276. doi: 10.1016/j.jaci.2015.05.002.
47. Fine JD, Eady RA, Bauer EA, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008;58(6):931–950. doi: 10.1016/j.jaad.2008.02.004.
48. Shinkuma S. Dystrophic epidermolysis bullosa: a review. Clin Cosmet Investig Dermatol. 2015;8:275–284. doi: 10.2147/CCID.S54681.
49. Макарова С.Г., Намазова-Баранова Л.С., Мурашкин Н.Н., и др. Пищевая аллергия у детей с врожденным буллезным эпидермолизом. Результаты собственного наблюдательного исследования //Вестник Российской академии медицинских наук. — 2018. — Т.73. — №1. — C. 49–58. doi: 10.15690/vramn847.
Рецензия
Для цитирования:
Мурашкин Н.Н., Иванов Р.А., Савелова А.А., Федоров Д.В., Опрятин Л.А., Ахмад В. Роль эпидермального барьера в формировании пищевой аллергии у детей с генодерматозами. Педиатрическая фармакология. 2019;16(4):234-240. https://doi.org/10.15690/pf.v16i4.2053
For citation:
Murashkin N.N., Ivanov R.A., Savelova A.A., Fedorov D.V., Opryatin L.A., Ahmad W. Role of the Epidermal Barrier in the Formation of Food Allergies in Children with Genodermatosis. Pediatric pharmacology. 2019;16(4):234-240. (In Russ.) https://doi.org/10.15690/pf.v16i4.2053